SP Stenning
- Genetics top 2%
- Glioma Diagnosis and Treatment 9
-
- Sarcoma Diagnosis and Treatment 7
- Gastric Cancer Management and Outcomes 5
- Lung Cancer Treatments and Mutations 4
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 6
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 4
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 5
-
- Testicular diseases and treatments 13
SP Stenning
40 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 85
- Genetics 424
- Pulmonary and Respiratory Medicine 521
- Oncology 386
- Reproductive Medicine 110
- Pathology and Forensic Medicine 194
Countries citing papers authored by SP Stenning
This map shows the geographic impact of SP Stenning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SP Stenning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SP Stenning more than expected).
Fields of papers citing papers by SP Stenning
This network shows the impact of papers produced by SP Stenning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SP Stenning. The network helps show where SP Stenning may publish in the future.
Co-authorship network
The 25 scholars most cited alongside SP Stenning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 0 | |
| 2 | A RANDOMISED TRIAL OF PROCARBAZINE, CCNU AND VINCRISTINE (PCV) VS TEMOZOLOMIDE (5-DAY OR 21-DAY SCHEDULE) FOR RECURRENT HIGH GRADE GLIOMA (MRC BR12, ISRCTN83176944) | 2008 | 7 |
| 3 | Long term results of the MRC OEO2 randomized trial of surgery with or without preoperative chemotherapy in resectable esophageal cancer | 2008 | 11 |
| 4 | 2006 | 59 | |
| 5 | Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971) | 2005 | 12 |
| 6 | Randomised controlled trial of ABVD vs. two multi-drug regimens (MDRs) for advanced Hodgkin's lymphoma (HL): Initial results of UKLG LY09 (ISRCTN97144519). | 2004 | 1 |
| 7 | Randomised comparison of ABVD with two multi-drug regimens (MDRs) in the treatment of advanced Hodgkin lymphoma (HL): Initial results of the UKLG LY09 study (ISRCTN 97144519). | 2003 | 2 |
| 8 | Randomized trial of porcarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A medical research council trial | 2001 | 16 |
| 9 | Molecular markers and the prediction of prognosis and response to therapy in colon cancer | 1999 | 1 |
| 10 | Adjuvant bleomycin, vincristine and cisplatin (BOP) for high risk clinical stage I (HRCS 1) non-seminomatous germ cell tumours (NSGCT) - a Medical Research Council (MRC) pilot study. | 1998 | 12 |
| 11 | Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in primary CNS lymphoma (PCL)- BR06. | 1998 | 1 |
| 12 | Residual masses post-chemotherapy for germ cell tumour: content, clinical features and prognosis | 1998 | 1 |
| 13 | Value of CA15.3 in marking relapse in breast cancer | 1997 | 1 |
| 14 | 1997 | 51 | |
| 15 | 1997 | 34 | |
| 16 | Optimal field size in adjuvant radiotherapy (XRT) of stage I seminoma - a randomised trial | 1996 | 8 |
| 17 | 1996 | 68 | |
| 18 | Short course adjuvant chemotherapy in high risk stage I non-seminomatous germ cell tumours of the testis - preliminary report of an MRC study | 1992 | 4 |
| 19 | 1991 | 315 | |
| 20 | Prognostic factors for survival in advanced non-seminomatous germ cell tumours: A study by the Medical Research Council Testicular Tumours Working Party | 1990 | 17 |
About SP Stenning
SP Stenning is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Reproductive Medicine, having authored 41 papers that have together received 1.3k indexed citations. Recurring topics across this work include Testicular diseases and treatments (13 papers), Glioma Diagnosis and Treatment (9 papers), Sarcoma Diagnosis and Treatment (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Genetics (424 citations), Pulmonary and Respiratory Medicine (521 citations) and Oncology (386 citations). SP Stenning has collaborated with scholars based in United Kingdom, Denmark and United States. Frequent co-authors include NM Bleehen, Michel Seymour, Graham M. Mead, R.T.D. Oliver, David Cunningham, W H Allum, Simon Weeden, K Birbeck, Clare Walker and Philip Quirke. Their work appears in journals such as Journal of Clinical Oncology, Clinical Oncology, British Journal of Cancer, Annals of Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.